Related Experiment Video
Updated: Sep 30, 2025

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
Risk stratifying gastric ulcers: development and validation of a scoring system
William M Brindle1, Rebecca K Grant1, Marianne Smith1
1The Centre for Liver and Digestive Disorders, Royal Infirmary of Edinburgh, Edinburgh, UK.
Routine endoscopic follow-up for gastric ulcers may not be necessary for all patients. A new risk score can identify low-risk cases, avoiding unnecessary procedures and focusing on high-risk individuals for early cancer detection.
Area of Science:
- Gastroenterology
- Oncology
- Medical Diagnostics
Background:
- The necessity of routine endoscopic follow-up for gastric ulcer healing remains debated.
- Accurate risk stratification is crucial for optimizing patient management and resource allocation.
Purpose of the Study:
- To evaluate the utility of follow-up oesophago-gastro-duodenoscopies (OGDs) for gastric ulcer healing.
- To develop and validate a risk score for stratifying patients based on malignancy risk.
Main Methods:
- Retrospective analysis of patients diagnosed with gastric ulcers undergoing index OGDs.
- Logistic regression was used to identify factors associated with malignancy and derive a risk score.
- External validation of the derived risk score was performed.
Main Results:
- Older age, larger ulcer size, and non-antral location were significantly associated with malignancy.
- The derived risk score demonstrated high accuracy (AUC 0.868, validated AUC 0.862) in distinguishing between benign and malignant ulcers.
- A low risk score combined with benign ulcer appearance and negative biopsies showed a high negative predictive value (NPV 97.4%, validated NPV 98.6%) for malignancy.
Conclusions:
- Patients with macroscopically benign gastric ulcers, negative biopsies, and a low-risk score may not require routine endoscopic follow-up.
- The developed risk score aids in identifying patients who can safely forgo follow-up OGDs, thereby improving efficiency in gastric ulcer management.
More Related Videos
05:50Author Spotlight: Point-of-Care Ultrasound for Gastric Content Assessment and Risk Stratification in Perioperative Care
Published on: September 22, 2023
09:11Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
Published on: February 14, 2021
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors